Specifically, 15% of low-grade localized tumors expressed p130Cas, while 48% of high-grade tumors and 80% of Castration-resistant prostate cancers exhibited p130Cas expression [126]. This evidence concerns the gene BCAR1 and Familial prostate cancer.